Acute Kidney Injury Clinical Trials in Rochester, Minnesota
4 studies are recruiting for acute kidney injury in Rochester, Minnesota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Neutrophil and Monocyte Deactivation Via the SeLective CytopheretIc Device - A Randomized Clinical Trial in Acute Kidney Injury
This randomized, controlled, pivotal study is intended to determine whether up to ten sequential 24-hour treatments with the Selective Cytopheretic Device (SCD) will improve survival in patients with Acute Kidney Injury (AKI) requiring continuous kidney replacement therapy (CKRT) when compared to C…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Locations
- 36 in total
- Run by
- SeaStar Medical
-
LoW Dose-Intensity vs. Standard Dose-Intensity COntinuous Renal ReplaceMent Therapy in Critically Ill Patients (WISDOM)
An estimated 10-15% of critically ill patients with acute kidney failure in the intensive care unit receive acute dialysis therapy. The majority of these patients initially receive a continuous form of dialysis therapy call continuous renal replacement therapy (CRRT). Prior studies have suggested t…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Locations
- 10 in total
- Run by
- University of Alberta
-
Acute Kidney Injury In Care Transitions (ACT): Pragmatic Clinical Trial
The purpose of this study is to determine the effect of a multidisciplinary intervention at care transitions for acute kidney injury survivors on patient-centered outcomes.
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Mayo Clinic in Rochester, Rochester, Minnesota
- Locations
- 3 in total
- Run by
- Mayo Clinic
-
CTSN Embolic Protection Trial
This is a prospective, multi-center, randomized effectiveness trial of the CardioGard Embolic Protection Cannula in high-risk valve surgery patients.
- Stage
- Not phased
- Ages
- 60 and older
- Site
- Mayo Clinic, Rochester, Minnesota
- Locations
- 28 in total
- Run by
- Icahn School of Medicine at Mount Sinai
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.